IRICoR will be attending the upcoming Bio Europe Conference from November 12 to 14, 2012.
Dr. Steven Klein, Business Development Director of the Institute for Research in Immunology and Cancer — Commercialization of Research (IRICoR ), a Center of Excellence in Commercialization and Research will attend the 18th Annual International Partnering Conference Bio Europe 2012, in Hamburg Germany. This event is Europe’s largest partnering conference which gives to the participants an opportunity to learn about investment trends and meet with leading dealmakers, strategic partners in Life Sciences.
To learn more about Bio Europe 2012, or to arrange a meeting with IRICoR, click here:http://www.ebdgroup.com/bioeurope/index.php. Dr. Klein can also be reached at steven.klein@iricor.ca.
About IRICoR | Institute for Research in Immunology and Cancer – Commercialization of Research
IRICoR is a non-profit organization whose mandate is to accelerate the discovery, development and commercialization of novel drugs that originate from IRIC and Université de Montréal. IRICoR, as a Center of Excellence in Commercialization and Research, invests in highly innovative projects to rapidly transition them from academia to the market, while identifying the best development partners for these commercially-promising projects. For more information about IRICoR, please visit : www.iricor.ca.
Information
Steven J. Klein Ph.D., MBA
Director, Business Development
steven.klein@iricor.ca
T +1 514 343.6647